PGT group | Control group | t/x2 | P value | |
---|---|---|---|---|
No. of Cycles | 136 | 52 | – | – |
Duration of Infertility (year) | 2.92 ± 3.25 | 4.29 ± 2.51 | 2.751 | 0.007 |
Maternal Age | 31.23 ± 4.94 | 31.02 ± 4.78 | −0.261 | 0.794 |
BMI | 24.06 ± 3.66 | 23.53 ± 3.36 | −0.907 | 0.366 |
RSA | 16 (11.8%) | 0 (0.0%) | – | 0.007(Fisher’s exact test) |
Uterine Abnormality | 31 (22.8%) | 10 (19.2%) | 0.280 | 0.597 |
Hydrosalpinx | 13 (9.6%) | 7 (13.5%) | 0.603 | 0.438 |
Uterine Leiomyoma | 8 (5.9%) | 3 (5.8%) | – | 1.000(Fisher’s exact test) |
Previous Pelvic or Intrauterine Surgery | 53 (39.0%) | 26 (50.0%) | 1.878 | 0.171 |
COH protocols | ||||
Long GnRH agonist | 87 (64.0%) | 30 (57.7%) | 0.631 | 0.427 |
Short GnRH agonist | 36 (26.5%) | 8 (15.4%) | 2.579 | 0.108 |
GnRH-antagonist | 11 (8.1%) | 13 (25.0%) | 9.661 | 0.002 |
other protocols | 2 (1.5%) | 1 (1.9%) | – | 1.000(Fisher’s exact test) |
No. of days of ovarian stimulation | 9.74 ± 2.20 | 9.88 ± 2.12 | 0.400 | 0.690 |
Gonadotropin dose (IU) | 1880.19 ± 910.67 | 1797.36 ± 1051.31 | −0.534 | 0.594 |
Cumulative Live birth rate | 67 (49.3%) | 26 (50.0%) | 0.008 | 0.928 |
First Transfer per cycle | ||||
Live birth rate | 55 (40.4%) | 20 (38.5%) | 0.061 | 0.804 |
Chemical pregnancy rate | 84 (61.8%) | 33 (63.5%) | 0.046 | 0.830 |
Clinical pregnancy rate | 73 (53.7%) | 27 (51.9%) | 0.046 | 0.829 |
Ongoing pregnancy rate | 70 (51.5%) | 27 (51.9%) | 0.003 | 0.956 |
Miscarriage rate | 7 (8.3%) | 3 (9.1%) | 0.017 | 0.895 |